Breast Cancer Drug Neratinib Shows Promise in Melting Artery Cholesterol

• Neratinib, a breast cancer drug, may melt and remove stubborn cholesterol from arteries, offering a new solution for heart disease.
• Tests on mice showed Neratinib can loosen or eliminate old plaque and reduce inflammation associated with atherosclerosis.
• Atherosclerosis, the accumulation of fat in arteries, is a major cause of heart attacks and heart disease.
• Dr. Jane Smith from the University of Health Sciences leads the study, highlighting Neratinib's potential for drug repurposing.
• Clinical trials for Neratinib's use in heart disease are expected to proceed faster due to its existing approval for cancer.

Why It Matters: A breast cancer drug, Neratinib, shows significant potential in clearing arterial cholesterol, offering hope for heart disease prevention.